Vaginal and urinary microbiota in breast cancer survivors undergoing fractional CO2 laser therapy
Abstract
Genitourinary syndrome of menopause (GSM) is common in breast cancer survivors (BCSs) receiving endocrine therapy, and non-hormonal treatment options remain limited. Fractional CO₂ laser therapy has been investigated as a non-hormonal treatment option, but its influence on the genitourinary microbiota remains unclear. We conducted a prospective study of BCSs with GSM undergoing five sessions of laser therapy. Vaginal swabs and midstream urine samples were collected before the first treatment and after the final treatment. Microbiota profiles (only bacteria here) were generated using Nanopore long-read 16 S rRNA gene sequencing targeting the V1–V8 region and temporal changes in alpha and beta diversity were evaluated. Twenty-six participants completed both sampling time points. The vaginal microbiota was predominantly Lactobacillus -dominated and showed no detectable change in alpha diversity or overall community composition after treatment. In contrast, the urinary microbiota displayed greater interindividual variability and a reproducible shift in overall community composition from baseline to follow-up. These urinary shifts persisted after adjustment for relevant clinical covariates and were not explained by consistent changes in individual taxa on differential abundance testing. Functional pathway profiles were unchanged in both vaginal and urinary samples. Overall, the vaginal microbiota remained largely stable between baseline and follow-up, whereas a modest temporal difference in urinary microbial community structure was observed. Further randomized controlled trials are needed, to elucidate whether these changes in urine microbiota are the result of laser therapy or are the results of other temporal changes in the women.
Related
- A comprehensive genetic study of the vaginal microbiota composition of Holstein cows
- Integrated microbiome and metabolomic analysis reveals associations between vaginal microbiota composition and psychological profiles
- Large-scale metagenomic characterization of the vaginal microbiome and uropathogens in women with recent bacterial vaginosis and urinary tract infections
- Chlamydia trachomatis Incidence in Relation to Vaginal Microbiota Dynamics, Immunogenetics and Exposures in a Cohort of Young Student Women in France
- The impact of the estrous cycle on the vaginal microbiota of dairy cows
BibTeX
@article{jacobsen2026vaginal,
title = {{Vaginal and urinary microbiota in breast cancer survivors undergoing fractional CO2 laser therapy}},
author = {Sine Jacobsen and Caspar Bundgaard-Nielsen and Marianne Glavind-Kristensen and Anders Bonde Jensen and Axel Forman and Suzette Sørensen and Pinar Bor},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-74343-4},
url = {https://www.nature.com/articles/s41598-026-74343-4},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Vaginal and urinary microbiota in breast cancer survivors undergoing fractional CO2 laser therapy
AU - Sine Jacobsen
AU - Caspar Bundgaard-Nielsen
AU - Marianne Glavind-Kristensen
AU - Anders Bonde Jensen
AU - Axel Forman
AU - Suzette Sørensen
AU - Pinar Bor
PY - 2026
DA - 2026/10/08
JO - Scientific Reports
DO - 10.1038/s41598-026-74343-4
UR - https://www.nature.com/articles/s41598-026-74343-4
AB - Genitourinary syndrome of menopause (GSM) is common in breast cancer survivors (BCSs) receiving endocrine therapy, and non-hormonal treatment options remain limited. Fractional CO₂ laser therapy has been investigated as a non-hormonal treatment option, but its influence on the genitourinary microbiota remains unclear. We conducted a prospective study of BCSs with GSM undergoing five sessions of laser therapy. Vaginal swabs and midstream urine samples were collected before the first treatment and after the final treatment. Microbiota profiles (only bacteria here) were generated using Nanopore long-read 16 S rRNA gene sequencing targeting the V1–V8 region and temporal changes in alpha and beta diversity were evaluated. Twenty-six participants completed both sampling time points. The vaginal microbiota was predominantly Lactobacillus -dominated and showed no detectable change in alpha diversity or overall community composition after treatment. In contrast, the urinary microbiota displayed greater interindividual variability and a reproducible shift in overall community composition from baseline to follow-up. These urinary shifts persisted after adjustment for relevant clinical covariates and were not explained by consistent changes in individual taxa on differential abundance testing. Functional pathway profiles were unchanged in both vaginal and urinary samples. Overall, the vaginal microbiota remained largely stable between baseline and follow-up, whereas a modest temporal difference in urinary microbial community structure was observed. Further randomized controlled trials are needed, to elucidate whether these changes in urine microbiota are the result of laser therapy or are the results of other temporal changes in the women.
SN - 2045-2322
ER -